Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients.

Fernández-Barat L, Motos A, Panigada M, Álvarez-Lerma F, Viña L, Lopez-Aladid R, Ceccato A, Bassi GL, Nicolau DP, Lopez Y, Muñoz L, Guerrero L, Soy D, Israel T, Castro P, Torres A.

Crit Care. 2019 Jul 10;23(1):251. doi: 10.1186/s13054-019-2523-5.

PMID:
31291978
Free Article
2.

Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis.

Alcaraz-Serrano V, Fernández-Barat L, Scioscia G, Llorens-Llacuna J, Gimeno-Santos E, Herrero-Cortina B, Vàzquez N, Puig de la Bellacasa J, Gabarrús A, Amaro-Rodriguez R, Menéndez R, Torres A.

Respir Med. 2019 Jul - Aug;154:40-46. doi: 10.1016/j.rmed.2019.06.012. Epub 2019 Jun 11.

PMID:
31212120
3.

Short-Term Appraisal of the Effects and Safety of Manual Versus Ventilator Hyperinflation in an Animal Model of Severe Pneumonia.

Li Bassi G, Martí JD, Comaru T, Aguilera-Xiol E, Rigol M, Ntoumenopoulos G, Terraneo S, De Rosa F, Rinaudo M, Fernandez-Barat L, Battaglini D, Meli A, Ferrer M, Pelosi P, Chiumello D, Torres A.

Respir Care. 2019 Jul;64(7):760-770. doi: 10.4187/respcare.06487. Epub 2019 May 14.

PMID:
31088989
4.

Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study.

Li Bassi G, Motos A, Fernandez-Barat L, Aguilera Xiol E, Chiurazzi C, Senussi T, Saco MA, Fuster C, Carbonara M, Bobi J, Amaro R, De Rosa F, Comaru T, Yang H, Ranzani OT, Marti JD, Rinaudo M, Comino Trinidad O, Rigol M, Bringué J, Ramirez J, Nicolau DP, Pelosi P, Antonelli M, Blasi F, Artigas A, Montgomery AB, Torres A.

Crit Care Med. 2019 Jun;47(6):e470-e477. doi: 10.1097/CCM.0000000000003724.

PMID:
30882478
5.

Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes.

Fernández-Barat L, Ben-Aicha S, Motos A, Vila J, Marco F, Rigol M, Muñoz L, Li Bassi G, Ferrer M, Torres A.

Sci Rep. 2018 Aug 9;8(1):11906. doi: 10.1038/s41598-018-30494-7.

6.

Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations.

Menéndez R, Méndez R, Polverino E, Rosales-Mayor E, Amara-Elori I, Reyes S, Sahuquillo-Arce JM, Fernández-Barat L, Alcaraz V, Torres A.

BMC Infect Dis. 2017 Sep 30;17(1):659. doi: 10.1186/s12879-017-2754-5.

7.

Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.

Menéndez R, Méndez R, Polverino E, Rosales-Mayor E, Amara-Elori I, Reyes S, Posadas T, Fernández-Barat L, Torres A.

Respir Res. 2017 Sep 30;18(1):176. doi: 10.1186/s12931-017-0659-x.

8.

Diagnostic Value of Endotracheal Aspirates Sonication on Ventilator-Associated Pneumonia Microbiologic Diagnosis.

Fernández-Barat L, Motos A, Ranzani OT, Bassi GL, Aguilera Xiol E, Senussi T, Travierso C, Chiurazzi C, Idone F, Muñoz L, Vila J, Ferrer M, Pelosi P, Blasi F, Antonelli M, Torres A.

Microorganisms. 2017 Sep 20;5(3). pii: E62. doi: 10.3390/microorganisms5030062.

9.

Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia.

Amaro R, Sellarés J, Polverino E, Cillóniz C, Ferrer M, Fernández-Barat L, Mensa J, Niederman MS, Torres A.

J Infect. 2017 May;74(5):442-449. doi: 10.1016/j.jinf.2017.01.009. Epub 2017 Jan 24.

PMID:
28130142
10.

Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.

Fernández-Barat L, Ferrer M, De Rosa F, Gabarrús A, Esperatti M, Terraneo S, Rinaudo M, Li Bassi G, Torres A.

J Infect. 2017 Feb;74(2):142-152. doi: 10.1016/j.jinf.2016.11.008. Epub 2016 Nov 16.

PMID:
27865895
11.

Biofilms in ventilator-associated pneumonia.

Fernández-Barat L, Torres A.

Future Microbiol. 2016 Dec;11:1599-1610. Epub 2016 Nov 10. Review.

PMID:
27831764
12.

Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.

Fernández-Barat L, Ciofu O, Kragh KN, Pressler T, Johansen U, Motos A, Torres A, Hoiby N.

J Cyst Fibros. 2017 Mar;16(2):222-229. doi: 10.1016/j.jcf.2016.08.005. Epub 2016 Sep 17.

13.

Tracheal tube biofilm removal through a novel closed-suctioning system: an experimental study.

Aguilera Xiol E, Li Bassi G, Wyncoll D, Ntoumenopoulos G, Fernandez-Barat L, Marti JD, Comaru T, De Rosa F, Rigol M, Rinaudo M, Ferrer M, Torres A.

Br J Anaesth. 2015 Nov;115(5):775-83. doi: 10.1093/bja/aev340.

14.

Endotracheal tube biofilm translocation in the lateral Trendelenburg position.

Li Bassi G, Fernandez-Barat L, Saucedo L, Giunta V, Marti JD, Tavares Ranzani O, Aguilera Xiol E, Rigol M, Roca I, Muñoz L, Luque N, Esperatti M, Saco MA, Ramirez J, Vila J, Ferrer M, Torres A.

Crit Care. 2015 Feb 27;19:59. doi: 10.1186/s13054-015-0785-0.

15.

Impact of COPD in the outcome of ICU-acquired pneumonia with and without previous intubation.

Rinaudo M, Ferrer M, Terraneo S, De Rosa F, Peralta R, Fernández-Barat L, Li Bassi G, Torres A.

Chest. 2015 Jun;147(6):1530-1538. doi: 10.1378/chest.14-2005.

PMID:
25612147
16.

Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.

Martin-Loeches I, Torres A, Rinaudo M, Terraneo S, de Rosa F, Ramirez P, Diaz E, Fernández-Barat L, Li Bassi GL, Ferrer M.

J Infect. 2015 Mar;70(3):213-22. doi: 10.1016/j.jinf.2014.10.004. Epub 2014 Oct 27.

PMID:
25445887
17.

New developments in the diagnosis of VAP make bronchoalveolar lavage less useful: some considerations.

Torres A, Fernández-Barat L.

Intensive Care Med. 2014 Nov;40(11):1778-9. doi: 10.1007/s00134-014-3466-6. Epub 2014 Sep 11. No abstract available.

PMID:
25209130
18.

A novel porcine model of ventilator-associated pneumonia caused by oropharyngeal challenge with Pseudomonas aeruginosa.

Li Bassi G, Rigol M, Marti JD, Saucedo L, Ranzani OT, Roca I, Cabanas M, Muñoz L, Giunta V, Luque N, Rinaudo M, Esperatti M, Fernandez-Barat L, Ferrer M, Vila J, Ramirez J, Torres A.

Anesthesiology. 2014 May;120(5):1205-15. doi: 10.1097/ALN.0000000000000222.

PMID:
24618700
19.

Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes.

Fernández-Barat L, Ferrer M, Sierra JM, Soy D, Guerrero L, Vila J, Li Bassi G, Cortadellas N, Martínez-Olondris P, Rigol M, Esperatti M, Luque N, Saucedo LM, Agustí C, Torres A.

Crit Care Med. 2012 Aug;40(8):2385-9. doi: 10.1097/CCM.0b013e31825332fc.

PMID:
22622402
20.

Direct analysis of bacterial viability in endotracheal tube biofilm from a pig model of methicillin-resistant Staphylococcus aureus pneumonia following antimicrobial therapy.

Fernández-Barat L, Li Bassi G, Ferrer M, Bosch A, Calvo M, Vila J, Gabarrús A, Martínez-Olondris P, Rigol M, Esperatti M, Luque N, Torres A.

FEMS Immunol Med Microbiol. 2012 Jul;65(2):309-17. doi: 10.1111/j.1574-695X.2012.00961.x. Epub 2012 Apr 23.

21.

New therapy options for MRSA with respiratory infection/pneumonia.

Ramirez P, Fernández-Barat L, Torres A.

Curr Opin Infect Dis. 2012 Apr;25(2):159-65. doi: 10.1097/QCO.0b013e3283509cfa. Review.

PMID:
22248980

Supplemental Content

Loading ...
Support Center